Literature DB >> 10075659

Conformation and self-association of human recombinant transforming growth factor-beta3 in aqueous solutions.

J Pellaud1, U Schote, T Arvinte, J Seelig.   

Abstract

The transforming growth factors-beta (TGF-beta) are important regulatory peptides for cell growth and differentiation with therapeutic potential for wound healing. Among the several TGF-beta isoforms TGF-beta3 has a particularly low solubility at physiological pH and easily forms aggregates. A spectroscopic structural analysis of TGF-beta3 in solution has thus been difficult. In this study, circular dichroism spectroscopy was used to determine the secondary structural elements of TGF-beta3. In addition, the aggregation of TGF-beta3 was investigated systematically as a function of pH and salt concentration using a rapid screening method. Sedimentation equilibrium and sedimentation velocity analysis revealed that TGF-beta3 exists predominantly in two major forms: (i) monomers in solution at low pH and (ii) large precipitating aggregates at physiological pH. Under acidic conditions (pH < 3.8) the protein was not aggregated. At pH approximately 3.9, a monomer right arrow over left arrow dimer equilibrium could be detected that transformed into larger aggregates at pH > 4.1. Aggregation was pronounced in the pH range of 4.3 < pH < 9.8 with the aggregation maximum between pH 6.5 and 8. 5. The aggregation process was accompanied by a structural change of the protein. The CD spectra were characterized by an isodichroic point at 209.5 nm indicating a two-state equilibrium between TGF-beta3 dissolved in solution and aggregated TGF-beta3. Aggregated TGF-beta3 showed a higher beta-sheet content and lower beta-turn and random coil contributions compared with monomeric TGF-beta3. Both the solution structure and the aggregate structure of TGF-beta3 were different from the crystal structure. This was in contrast to TGF-beta2, which showed very similar crystal and solution structures. Under alkaline conditions (pH > 9.8) the turbidity disappeared and a further conformational change was induced. The pH dependence of the TGF-beta3 conformation in solution in the range of 2.3 < pH < 11. 0 was reversible. Aggregation of TGF-beta3 was, furthermore, influenced by the presence of salt. For pH > 3.8 the addition of salt greatly enhanced the tendency to aggregate, even in the very basic domain. Under physiological conditions (pH 7.4, cNaCl = 164 mM) TGF-beta3 has almost the highest tendency to aggregate and will remain in solution only at nanomolar concentrations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10075659     DOI: 10.1074/jbc.274.12.7699

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  BMP-2 and TGF-β3 do not prevent spontaneous degeneration in rabbit disc explants but induce ossification of the annulus fibrosus.

Authors:  Daniel Haschtmann; Stephen J Ferguson; Jivko V Stoyanov
Journal:  Eur Spine J       Date:  2012-05-26       Impact factor: 3.134

2.  Transforming growth factor-β3 (TGF-β3) knock-in ameliorates inflammation due to TGF-β1 deficiency while promoting glucose tolerance.

Authors:  Bradford E Hall; Umesh D Wankhade; Joanne E Konkel; Karthik Cherukuri; Chandrasekharam N Nagineni; Kathleen C Flanders; Praveen R Arany; Wanjun Chen; Sushil G Rane; Ashok B Kulkarni
Journal:  J Biol Chem       Date:  2013-09-20       Impact factor: 5.157

3.  New strategy for high-level expression and purification of biologically active monomeric TGF-β1/C77S in Escherichia coli.

Authors:  Yana V Kim; Marine E Gasparian; Eduard V Bocharov; Rita V Chertkova; Elena N Tkach; Dmitry A Dolgikh; Mikhail P Kirpichnikov
Journal:  Mol Biotechnol       Date:  2015-02       Impact factor: 2.695

4.  Sequence-specific 1H and 15N assignment and secondary structure of transforming growth factor beta3.

Authors:  E V Bocharov; M J Blommers; J Kuhla; T Arvinte; R Bürgi; A S Arseniev
Journal:  J Biomol NMR       Date:  2000-02       Impact factor: 2.835

5.  An engineered transforming growth factor β (TGF-β) monomer that functions as a dominant negative to block TGF-β signaling.

Authors:  Sun Kyung Kim; Lindsey Barron; Cynthia S Hinck; Elyse M Petrunak; Kristin E Cano; Avinash Thangirala; Brian Iskra; Molly Brothers; Machell Vonberg; Belinda Leal; Blair Richter; Ravindra Kodali; Alexander B Taylor; Shoucheng Du; Christopher O Barnes; Traian Sulea; Guillermo Calero; P John Hart; Matthew J Hart; Borries Demeler; Andrew P Hinck
Journal:  J Biol Chem       Date:  2017-02-22       Impact factor: 5.157

6.  Ion-specific modulation of protein interactions: anion-induced, reversible oligomerization of a fusion protein.

Authors:  Yatin R Gokarn; R Matthew Fesinmeyer; Atul Saluja; Shawn Cao; Jane Dankberg; Andrew Goetze; Richard L Remmele; Linda O Narhi; David N Brems
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

7.  A cytokine-neutralizing antibody as a structural mimetic of 2 receptor interactions.

Authors:  Christian Grütter; Trevor Wilkinson; Richard Turner; Sadhana Podichetty; Donna Finch; Matthew McCourt; Scott Loning; Lutz Jermutus; Markus G Grütter
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-10       Impact factor: 11.205

8.  TGF-β2 uses the concave surface of its extended finger region to bind betaglycan's ZP domain via three residues specific to TGF-β and inhibin-α.

Authors:  Morkos A Henen; Pardeep Mahlawat; Christian Zwieb; Ravindra B Kodali; Cynthia S Hinck; Ramsey D Hanna; Troy C Krzysiak; Udayar Ilangovan; Kristin E Cano; Garrett Hinck; Machell Vonberg; Megan McCabe; Andrew P Hinck
Journal:  J Biol Chem       Date:  2018-12-31       Impact factor: 5.157

9.  TbetaR-II discriminates the high- and low-affinity TGF-beta isoforms via two hydrogen-bonded ion pairs.

Authors:  Jason Baardsnes; Cynthia S Hinck; Andrew P Hinck; Maureen D O'Connor-McCourt
Journal:  Biochemistry       Date:  2009-03-17       Impact factor: 3.162

10.  Biological activity differences between TGF-β1 and TGF-β3 correlate with differences in the rigidity and arrangement of their component monomers.

Authors:  Tao Huang; Seth L Schor; Andrew P Hinck
Journal:  Biochemistry       Date:  2014-09-05       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.